Anna Goździk
University of Wrocław
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anna Goździk.
Polish archives of internal medicine | 2018
Marta Obremska; M. Boratyńska; Maciej Szymczak; Dorota Zyśko; Tomasz Płonek; Anna Goździk; Marian Klinger
INTRODUCTION Aortic root (AoR) dilation is associated with cardiac damage and higher cardiovascular risk. Cardiovascular disease is the most common cause of death in patients after kidney transplantation (KTx ). OBJECTIVES The aim of this study was to assess the prevalence of enlarged AoR diameter in KTx recipients. Patients with bicuspid aortic valve, significant valvular disease, or evidence of connective tissue disorder were excluded. PATIENTS AND METHODS A total of 87 KTx recipients were divided into 2 groups depending on immunosuppressive regimen: 41 patients receiving mammalian target of rapamycin inhibitors (mTORi) and 46 patients treated with calcineurin inhibitors (CNIs). In all patients, echocardiography was performed, laboratory and clinical markers of cardiovascular risk were assessed, and the AoR diameter was calculated. RESULTS There were no differences between groups in age, sex, body surface area, body mass index, frequency of diabetes, hypertension, dyslipidemia, time after replacement therapy, creatinine levels, and estimated glomerular filtration rate. In the CNI group, the observed and calculated AoR diameters were similar (P = 0.8). In the mTORi group, the observed AoR diameter was higher than the calculated one (P = 0.002). The concentric and eccentric left ventricular hypertrophy was similar in both groups (P = 0.12 and P = 0.69, respectively). In the stepwise regression analysis, the AoR diameter was associated with body surface area and mTORi treatment. CONCLUSIONS KTx recipients have a high prevalence of AoR dilation. Immunosuppressive regimen based on mTORi increases the incidence of AoR enlargement.
Folia Cardiologica | 2017
Dariusz Dąbrowski; Anna Goździk; Aleksandra Milnerowicz; Jacek Jakubaszko; Waldemar Goździk; Wojciech Kosmala
Left ventricular myxoma is a very rare, benign primary cardiac tumor. Due to its localization, size and mobility, it may be a source of peripheral embolism. The recurrence of myxoma after surgical removal is rare, ranging from 0% to 3% in solitary tumors and 12–22% in the familial type. We report two cases of left ventricular myxomas complicated by arterial embolism. In the first case of a 19-years old male, apart from systemic embolisation, a very fast tumor growth, suggesting thrombus formation, was observed. In the second case of a 42-years old male, the recurrence of myxoma in left ventricle apex was found 2 months after surgical excision, together with de novo development of two additional tumors in the right atrium. Clinical features of cardiac myxoma, both in terms of complications and recurrences, necessitate careful follow up with an echocardiographic control in all patients after tumor removal surgery.
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery | 2015
Maciej Rachwalik; Dorota Zyśko; Grzegorz Bielicki; Marta Obremska; Anna Goździk; Wojciech Kustrzycki
Surgical ablation is a recommended procedure for patients with atrial fibrillation (AF) undergoing a cardiac surgery operation. However, the procedure is associated with significant risk of late recurrence of AF. The aim of the study was to assess the long-term efficacy of the procedure with respect to the comorbidities. The study group consisted of 22 patients: 9 women and 13 men, who underwent surgical AF ablation in the 2008-2013 period. The patients were interviewed by telephone and were asked to send their recently performed 12-lead electrocardiography (ECG). The semi-structured interview consisted of 25 items regarding the history of AF, concomitant comorbidities, lifelong syncopal history, smoking, family history of premature cardiovascular diseases, and current medical treatment. Furthermore, the Epworth test was performed to measure the daytime sleepiness, which in turn is related to the presence of obstructive sleep apnoea. On the basis of the obtained data, the CHADS2, and Epworth scale scores were calculated for each patient. As a result of the study six patients (27%) had sinus rhythm or paced dual chamber rhythm, and 16 patients had atrial fibrillation. The multivariate analysis revealed that Epworth scale scoring > 9, CHADS2 score > 0, and persistent type of AF were related to poor outcome of surgical ablation procedure. In conclusion, patients with AF treated with surgical ablation have similar prognosis of sinus rhythm maintenance to those treated with radiofrequency ablation. Moreover, the same predisposing factors play a significant role in AF recurrence both in surgical patients and in patients treated with radiofrequency ablation.
Advances in Clinical and Experimental Medicine | 2015
Anna Goździk; Jacek Jakubaszko; Tomasz Grzebieniak; Wojciech Kustrzycki; Waldemar Goździk
BACKGROUND The number of patients with chronic kidney failure requiring cardiac surgery is continuously increasing. Additionally, significant worsening in the overall risk profile of this group of patients is noted. OBJECTIVES To investigate the effect of chronic renal dysfunction both in non-dialysis-dependent renal failure and end-stage renal failure patients, on early mortality--morbidity and late survival in a series of cardiac surgery patients at our institution. MATERIAL AND METHODS 1344 patients who had open heart surgery at our university hospital between 2010 and 2013 were retrospectively reviewed. Chronic renal dysfunction was defined according to preoperative glomerular filtration rate. Patients selection (n=80). Group 1 mild--(GRF 59-30 mL/min), Group 2 moderate--(GFR 29-15 mL/min), Group 3 end stage--(GFR<15 mL/min) renal failure. RESULTS Chronic renal dysfunction was present in 5.95% of all patients studied. Group 1--55 (68.75%), Group 2--16 (20%), Group 3--9 (11.25%). No difference between the groups in the need for heart inotropic support was noted; however the use of these medications was necessary in 60.6% of all studied patients. Forty nine percent in Group 1, 87.5% in Group 2 and 77% in Group 3, respectively. Renal replacement therapy in the early postoperative period was needed in 12 patients, with significance between the groups (p = 0.001). The overall hospital mortality was 2.5%. Follow-up was completed with a mean of 1.4 years (range 2 months to 4 years). There were 6 (7.5%) late deaths. CONCLUSIONS Our observations do not exhibit large variations in postoperative complications and deaths in patients with chronic renal failure, depending on the degree of preoperative renal function impairment. It seems that renal failure regardless of the degree of impairment is a factor aggravating the intra and post-operative course in cardiac surgery patients.
Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine | 2016
Marta Obremska; M. Boratyńska; Dorota Zyśko; Maciej Szymczak; Jacek Kurcz; Anna Goździk; Maciej Rachwalik; Marian Klinger
Kardiologia Polska | 2006
Wiktor Kuliczkowski; Anna Goździk; Marcin Protasiewicz; Marta Negrusz-Kawecka; Walentyna Mazurek
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery | 2012
Waldemar Goździk; Anna Goździk
Kardiologia Polska | 2004
Marek Pelczar; Anna Goździk; Arkadiusz Derkacz; Małgorzata Lipińska-Gediga; Wojciech Kustrzycki
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery | 2012
Waldemar Goździk; Anna Goździk
Medical Science and Technology | 2010
Maciej Rachwalik; Marta Obremska; Anna Goździk